I love seeing fantastic science turn into new commercial and social opportunities.

At the University of Bristol, I helped find technology-market-fit and spin out multiple companies. From this experience, I co-founded and led a synthetic biology company, which transformed fundamental protein design research into a clinical trial-ready diagnostics platform.

In my current role at Revena, I help high-growth companies develop their technical and product roadmaps, and conduct technical assessments for venture capital investors. I'm excited to meet the next generation of deeptech entrepreneurs and support their creative use of engineering biology.